COLLABORATING AND PARTNERING WITH THE HIV COMMUNITY
At ViiV Healthcare, our ambition is to make HIV a smaller part of people’s lives. The Positive Perspectives research (Waves 1, 2 and 3) forms part of our ongoing commitment to people living with HIV, enabling us to better understand the experience evolving needs and challenges faced by a diverse group of participants across the world.
The Positive Perspectives work remains true to our belief in the importance of ensuring meaningful involvement of people living with HIV, aligned with the Denver Principles. The Advisory Committees for this research involved members of the global HIV community including people living with HIV, advocates and healthcare providers.
Why is the positive perspectives research important?
Few international HIV studies capture the experiences of people living with HIV beyond viral suppression. Positive Perspectives is an opportunity to hear how people living with HIV across the world think, feel, and live. Results from the Positive Perspectives research encourage people living with HIV and their healthcare providers to look beyond viral suppression and focus on health-related quality of life.
Positive Perspectives Wave survey
Wave 3 survey
Positive Perspective wave 3 will be used to further amplify the voices of people living with HIV, with the objective of improving treatment, care and outcomes through improved communication of these data to HCPs and stakeholders within healthcare systems.
Full results will be presented towards the end of 2025.
Resources
[Coming soon]
Wave 2 survey
Positive Perspectives 2 is one of the largest, global, HIV-specific patient experience studies to date. Positive Perspectives Wave 2 built on Wave 1 by expanding the number of people included, the number of countries the research was conducted and the themes explored in the study.
The wave 2 of the Positive Perspectives research involved:
The key domains covered in Wave 2 were:
- Taking multiple treatments (polypharmacy)
- The importance of open dialogue between people living with HIV and their and healthcare providers
- Ageing well with HIV
- Women & HIV
- Undetectable = Untransmittable and the impact this knowledge can have on health outcomes
Positive Perspectives results from Wave 2 are available below
Resources
Wave 1 survey
Positive Perspectives Wave 1, was the first patient experience study of its kind, that set out to capture the experiences and opinions of a large and diverse international group of people living with HIV, on the topics of the psychosocial aspects of living with HIV, dialogues between patient and healthcare providers and satisfaction with current antiretroviral therapies.
The first wave was conducted as market research. The survey included:
Key themes explored in Wave 1:
- Diagnosis
- Sharing status
- Stigma
- Managing treatment
- Communication between people living with HIV and their healthcare providers
Resources
You may also be Interested In
We believe in a comprehensive approach to HIV prevention that considers both medical and non-medical alternatives that are accessible to all. Ideally, a combination of strategies can be effective in reducing the likelihood of HIV transmission.
It is now established that if you’re on treatment and have an undetectable viral load, you cannot pass on HIV through sex. Undetectable = Untransmittable, or U=U. This simple equation has profound implications for everyone living with HIV, and for economies and governments around the world.
NP-GBL-HVX-COCO-220033 May 2025.
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
